John McMurray
Overview
Explore the profile of John McMurray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
4593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drozdz J, Morawiec R, Drozd M, Krzesinski P, Wozakowska-Kaplon B, Grabowski M, et al.
Kardiol Pol
. 2025 Jan;
PMID: 39743905
No abstract available.
2.
Lundberg S, Knigge P, Strange J, Nouhravesh N, Wagner A, Malik M, et al.
Am Heart J
. 2024 Aug;
278:83-92.
PMID: 39216691
Background: Despite improved survival, hospitalization is still common among patients with heart failure (HF). Objective: This study aimed to examine temporal trends in infection-related hospitalization among HF patients and compare...
3.
Omerovic E, Petrie M, Redfors B, Fremes S, Murphy G, Marquis-Gravel G, et al.
Trials
. 2024 Jan;
25(1):80.
PMID: 38263138
In an era focused on value-based healthcare, the quality of healthcare and resource allocation should be underpinned by empirical evidence. Pragmatic clinical trials (pRCTs) are essential in this endeavor, providing...
4.
Walli-Attaei M, Joseph P, Johansson I, Sliwa K, Lonn E, Maggioni A, et al.
Lancet Glob Health
. 2024 Jan;
12(3):e396-e405.
PMID: 38218197
Background: There is a paucity of data on the clinical characteristics, management, and outcomes of women compared with men with heart failure in low-income and middle-income countries compared with high-income...
5.
Bozkurt B, Desai A, Ahmad T, Deswal A, Heidenreich P, Ibrahim N, et al.
JACC Heart Fail
. 2023 Oct;
11(10):1466-1469.
PMID: 37793737
No abstract available.
6.
Sattar N, McMurray J, Boren J, Rawshani A, Omerovic E, Berg N, et al.
Circulation
. 2023 May;
147(25):1872-1886.
PMID: 37154040
Background: The goal of this work was to investigate trends (2001-2019) for cardiovascular events and cardiometabolic risk factor levels in individuals with type 2 diabetes (T2D) and matched control subjects....
7.
Bruhn J, Malmborg M, Garred C, Ravn P, Zahir D, Andersson C, et al.
Eur Heart J
. 2023 Jan;
44(13):1124-1132.
PMID: 36691953
Aims: Cancer and heart failure (HF) share risk factors, pathophysiological mechanisms, and possibly genetics. Improved HF survival may increase the risk of cancer due to a competing risk. Whether the...
8.
Thomson P, Mark P, Robertson M, White C, Anker S, Bhandari S, et al.
Kidney Int Rep
. 2022 Aug;
7(8):1793-1801.
PMID: 35967105
Introduction: Treatment of anemia in dialysis patients has been associated with increased risk of vascular access thrombosis (VAT). Proactive IV irOn Therapy in hemodiALysis Patients (PIVOTAL) was a clinical trial...
9.
Bedrouni W, Sharma A, Pitt B, Lam C, Ni J, Ferreira J, et al.
Circ Heart Fail
. 2022 Aug;
15(10):e009295.
PMID: 35924555
No abstract available.
10.
Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes
Malik M, Andersson C, Blanche P, Dsouza M, Madelaire C, Zareini B, et al.
Clin Res Cardiol
. 2022 Apr;
112(2):215-226.
PMID: 35396632
Importance: Updated guidelines on diabetes recommend targeting sodium-glucose cotransporter-2 inhibitors (SGLT2i) at patients at risk of heart failure (HF) and glucagon-like peptide-1 receptor agonists (GLP1-RA) at those at greater risk...